ReviewPrzeglad menopauzalny = Menopause review2026
Osteoporosis: current diagnostic possibilities, a literature review.
Review in Przeglad menopauzalny = Menopause review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis is recognised as a civilization disease characterised by reduced bone mineral density (BMD) and an increased risk of fractures, particularly among postmenopausal women and the elderly. Current data indicate that a significant portion of individuals suffering from osteoporosis remains undiagnosed, highlighting the need for the development of diagnostic methods. This literature review comprehensively analyses existing diagnostic methods for osteoporosis. A literature review was conducted utilising electronic databases, such as PubMed and Google Scholar, to identify relevant articles published up to 2025. Articles were searched by combining related terms, such as "osteoporosis diagnostics", "imaging diagnostics in osteoporosis" and "osteoporosis". Dual-energy X-ray absorptiometry effectively assesses BMD and helps evaluate fracture risk; however, due to its limitations, diagnosis may not always be timely, necessitating the use of supplementary methods. Imaging technologies such as computed tomography, quantitative computed tomography, and magnetic resonance imaging are being investigated for their potential to provide additional insights into bone microarchitecture and health, while reducing patient exposure to ionizing radiation. Moreover, advancements in artificial intelligence (AI), including deep learning (DL), show potential for improving diagnostics. Studies suggest that DL models demonstrate high sensitivity and specificity, creating potential for the development of screening tools using imaging data obtained during routine examinations. This article provides a critical review of current diagnostic possibilities in osteoporosis, emphasising the importance of a multifaceted approach that integrates traditional imaging and modern AI-based methodologies to enhance the early detection, prevention, and treatment of osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.